A	A	DT	B-NP	O	
general	general	JJ	I-NP	O	
strategy	strategy	NN	I-NP	O	
for	for	IN	B-PP	O	
the	the	DT	B-NP	O	
bacterial	bacterial	JJ	I-NP	O	
expression	expression	NN	I-NP	O	
of	of	IN	B-PP	O	
amyloidogenic	amyloidogenic	JJ	B-NP	O	
peptides	peptide	NNS	I-NP	O	
using	use	VBG	B-VP	O	
BCL	BCL	NN	B-NP	B-protein	
-	-	HYPH	B-NP	O	
XL	XL	NN	I-NP	B-DNA	
-1/2	-1/2	CD	B-NP	I-DNA	
fusions	fusion	NNS	I-NP	I-DNA	
.	.	.	O	O	

Biophysical	Biophysical	JJ	B-NP	O	
studies	study	NNS	I-NP	O	
on	on	IN	B-PP	O	
amyloidogenic	amyloidogenic	JJ	B-NP	O	
and	and	CC	I-NP	O	
aggregation	aggregation	NN	I-NP	O	
-	-	HYPH	O	O	
prone	prone	NN	B-NP	O	
peptides	peptide	NNS	I-NP	O	
often	often	RB	B-ADVP	O	
require	require	VBP	B-VP	O	
large	large	JJ	B-NP	O	
quantities	quantity	NNS	I-NP	O	
of	of	IN	B-PP	O	
material	material	NN	B-NP	O	
.	.	.	O	O	

However	However	RB	B-ADVP	O	
,	,	,	O	O	
solid	solid	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
phase	phase	NN	I-NP	O	
synthesis	synthesis	NN	I-NP	O	
,	,	,	O	O	
handling	handling	NN	B-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
purification	purification	NN	B-NP	O	
of	of	IN	B-PP	O	
peptides	peptide	NNS	B-NP	O	
often	often	RB	B-ADVP	O	
present	present	VBP	B-VP	O	
challenges	challenge	NNS	B-NP	O	
on	on	IN	B-PP	O	
these	these	DT	B-NP	O	
scales	scale	NNS	I-NP	O	
.	.	.	O	O	

Recombinant	Recombinant	JJ	B-NP	O	
expression	expression	NN	I-NP	O	
is	be	VBZ	B-VP	O	
an	an	DT	B-NP	O	
attractive	attractive	JJ	I-NP	O	
alternative	alternative	NN	I-NP	O	
because	because	IN	B-PP	O	
of	of	IN	I-PP	O	
its	its	PRP$	B-NP	O	
low	low	JJ	I-NP	O	
cost	cost	NN	I-NP	O	
,	,	,	O	O	
the	the	DT	B-NP	O	
ability	ability	NN	I-NP	O	
to	to	TO	B-VP	O	
isotopically	isotopically	RB	I-VP	O	
label	label	VB	I-VP	O	
the	the	DT	B-NP	O	
peptides	peptide	NNS	I-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
access	access	NN	B-NP	O	
to	to	TO	B-PP	O	
sequences	sequence	NNS	B-NP	O	
exceeding	exceed	VBG	B-VP	O	
approximately	approximately	RB	B-NP	O	
50	50	CD	I-NP	O	
residues	residue	NNS	I-NP	O	
.	.	.	O	O	

However	However	RB	B-ADVP	O	
,	,	,	O	O	
expression	expression	NN	B-NP	O	
systems	system	NNS	I-NP	O	
that	that	WDT	B-NP	O	
seek	seek	VBP	B-VP	O	
to	to	TO	I-VP	O	
solubilize	solubilize	VB	I-VP	O	
amyloidogenic	amyloidogenic	JJ	B-NP	O	
peptides	peptide	NNS	I-NP	O	
suffer	suffer	VBP	B-VP	O	
from	from	IN	B-PP	O	
low	low	JJ	B-NP	O	
yields	yield	NNS	I-NP	O	
,	,	,	O	O	
difficult	difficult	JJ	B-NP	O	
optimizations	optimization	NNS	I-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
isolation	isolation	NN	B-NP	O	
challenges	challenge	NNS	I-NP	O	
.	.	.	O	O	

We	We	PRP	B-NP	O	
present	present	VBP	B-VP	O	
a	a	DT	B-NP	O	
general	general	JJ	I-NP	O	
strategy	strategy	NN	I-NP	O	
for	for	IN	B-PP	O	
expressing	express	VBG	B-VP	O	
and	and	CC	I-VP	O	
isolating	isolate	VBG	I-VP	O	
amyloidogenic	amyloidogenic	JJ	B-NP	O	
peptides	peptide	NNS	I-NP	O	
in	in	IN	B-PP	O	
Escherichia coli	Escherichia_coli	NNP	B-NP	O	
by	by	IN	B-PP	O	
fusion	fusion	NN	B-NP	O	
to	to	TO	B-PP	O	
a	a	DT	B-NP	O	
polypeptide	polypeptide	NN	I-NP	O	
that	that	WDT	B-NP	O	
drives	drive	VBZ	B-VP	O	
the	the	DT	B-NP	O	
expression	expression	NN	I-NP	O	
of	of	IN	B-PP	O	
attached	attach	VBN	B-NP	O	
peptides	peptide	NNS	I-NP	O	
into	into	IN	B-PP	O	
bacterial	bacterial	JJ	B-NP	O	
inclusion	inclusion	NN	I-NP	O	
bodies	body	NNS	I-NP	O	
.	.	.	O	O	

This	This	DT	B-NP	O	
scheme	scheme	NN	I-NP	O	
minimizes	minimize	VBZ	B-VP	O	
toxicity	toxicity	NN	B-NP	O	
during	during	IN	B-PP	O	
bacterial	bacterial	JJ	B-NP	O	
growth	growth	NN	I-NP	O	
and	and	CC	O	O	
enables	enable	VBZ	B-VP	O	
the	the	DT	B-NP	O	
processing	processing	NN	I-NP	O	
and	and	CC	I-NP	O	
handling	handling	NN	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
peptides	peptide	NNS	I-NP	O	
in	in	IN	B-PP	O	
denaturing	denature	VBG	B-VP	O	
solutions	solution	NNS	B-NP	O	
.	.	.	O	O	

Immobilized	Immobilize	VBN	B-NP	O	
metal	metal	NN	I-NP	O	
affinity	affinity	NN	I-NP	O	
chromatography	chromatography	NN	I-NP	O	
,	,	,	O	O	
reverse	reverse	JJ	B-NP	O	
phase	phase	NN	I-NP	O	
HPLC	HPLC	NN	I-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
cyanogen	cyanogen	NN	B-NP	O	
bromide	bromide	NN	I-NP	O	
cleavage	cleavage	NN	I-NP	O	
are	be	VBP	B-VP	O	
used	use	VBN	I-VP	O	
to	to	TO	B-VP	O	
isolate	isolate	VB	I-VP	O	
the	the	DT	B-NP	O	
peptide	peptide	NN	I-NP	O	
,	,	,	O	O	
followed	follow	VBN	B-VP	O	
by	by	IN	B-PP	O	
further	further	JJ	B-NP	O	
reverse	reverse	JJ	I-NP	O	
phase	phase	NN	I-NP	O	
HPLC	HPLC	NN	I-NP	O	
,	,	,	O	O	
which	which	WDT	B-NP	O	
yields	yield	VBZ	B-VP	O	
milligram	milligram	NN	B-NP	O	
quantities	quantity	NNS	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
purified	purify	VBN	I-NP	O	
peptide	peptide	NN	I-NP	O	
.	.	.	O	O	

We	We	PRP	B-NP	O	
demonstrate	demonstrate	VBP	B-VP	O	
that	that	IN	B-SBAR	O	
driving	drive	VBG	B-VP	O	
the	the	DT	B-NP	O	
peptides	peptide	NNS	I-NP	O	
into	into	IN	B-PP	O	
inclusion	inclusion	NN	B-NP	O	
bodies	body	NNS	I-NP	O	
using	use	VBG	B-VP	O	
fusion	fusion	NN	B-NP	O	
to	to	TO	B-PP	O	
BCL	BCL	NN	B-NP	B-protein	
-	-	HYPH	O	O	
XL	XL	NN	B-NP	B-DNA	
-1/2	-1/2	CD	I-NP	I-DNA	
is	be	VBZ	B-VP	O	
a	a	DT	B-NP	O	
general	general	JJ	I-NP	O	
strategy	strategy	NN	I-NP	O	
for	for	IN	B-PP	O	
their	their	PRP$	B-NP	O	
expression	expression	NN	I-NP	O	
and	and	CC	I-NP	O	
isolation	isolation	NN	I-NP	O	
,	,	,	O	O	
as	as	IN	B-SBAR	O	
exemplified	exemplify	VBN	B-VP	O	
by	by	IN	B-PP	O	
the	the	DT	B-NP	O	
production	production	NN	I-NP	O	
of	of	IN	B-PP	O	
11	11	CD	B-NP	O	
peptides	peptide	NNS	I-NP	O	
species	specie	NNS	I-NP	O	
.	.	.	O	O	

